373 related articles for article (PubMed ID: 35743639)
21. The Indian scenario of head and neck oncology - Challenging the dogmas.
Tuljapurkar V; Dhar H; Mishra A; Chakraborti S; Chaturvedi P; Pai PS
South Asian J Cancer; 2016; 5(3):105-10. PubMed ID: 27606292
[TBL] [Abstract][Full Text] [Related]
22. Clinical immunotherapeutic approaches for the treatment of head and neck cancer.
Kareemaghay S; Tavassoli M
Int J Oral Maxillofac Surg; 2019 Apr; 48(4):419-436. PubMed ID: 30401512
[TBL] [Abstract][Full Text] [Related]
23. Immune-relevant aspects of murine models of head and neck cancer.
Rossa C; D'Silva NJ
Oncogene; 2019 May; 38(21):3973-3988. PubMed ID: 30696955
[TBL] [Abstract][Full Text] [Related]
24. [Establishment of a living biobank : Improved guidance of precision cancer care with in vitro and in vivo cancer models].
Pauli C; Moch H; Rubin MA
Pathologe; 2017 Nov; 38(Suppl 2):160-168. PubMed ID: 28956107
[TBL] [Abstract][Full Text] [Related]
25. Patient-derived tumour models for personalized therapeutics in urological cancers.
van de Merbel AF; van der Horst G; van der Pluijm G
Nat Rev Urol; 2021 Jan; 18(1):33-45. PubMed ID: 33173206
[TBL] [Abstract][Full Text] [Related]
26. Role of Non-coding RNAs on the Radiotherapy Sensitivity and Resistance of Head and Neck Cancer: From Basic Research to Clinical Application.
Zhang X; Yang J
Front Cell Dev Biol; 2020; 8():637435. PubMed ID: 33644038
[TBL] [Abstract][Full Text] [Related]
27. Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments.
Perrin SL; Samuel MS; Koszyca B; Brown MP; Ebert LM; Oksdath M; Gomez GA
Biochem Soc Trans; 2019 Apr; 47(2):625-638. PubMed ID: 30902924
[TBL] [Abstract][Full Text] [Related]
28. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
29. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
[TBL] [Abstract][Full Text] [Related]
30. Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity.
Tanaka N; Osman AA; Takahashi Y; Lindemann A; Patel AA; Zhao M; Takahashi H; Myers JN
Oral Oncol; 2018 Dec; 87():49-57. PubMed ID: 30527243
[TBL] [Abstract][Full Text] [Related]
31. Novel
Clark J; Fotopoulou C; Cunnea P; Krell J
Front Oncol; 2022; 12():837233. PubMed ID: 35402223
[TBL] [Abstract][Full Text] [Related]
32. Precision medicine in head and neck cancer.
Kaidar-Person O; Gil Z; Billan S
Drug Resist Updat; 2018 Sep; 40():13-16. PubMed ID: 30466712
[TBL] [Abstract][Full Text] [Related]
33. Management and potentialities of primary cancer cultures in preclinical and translational studies.
Miserocchi G; Mercatali L; Liverani C; De Vita A; Spadazzi C; Pieri F; Bongiovanni A; Recine F; Amadori D; Ibrahim T
J Transl Med; 2017 Nov; 15(1):229. PubMed ID: 29116016
[TBL] [Abstract][Full Text] [Related]
34. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
35. Lyophilized particles and ethanolic extracts of Antrodia cinnamomea mycelia suppress the tumorigenicity of head and neck cancer cells in vivo.
Chang CW; Chen YS; Chen CC; Chen CC; Sheu SJ; Lin TW; Lee TC; Lo JF
Biomedicine (Taipei); 2014; 4(4):26. PubMed ID: 25520939
[TBL] [Abstract][Full Text] [Related]
36. In vitro humanized 3D microfluidic chip for testing personalized immunotherapeutics for head and neck cancer patients.
Al-Samadi A; Poor B; Tuomainen K; Liu V; Hyytiäinen A; Suleymanova I; Mesimaki K; Wilkman T; Mäkitie A; Saavalainen P; Salo T
Exp Cell Res; 2019 Oct; 383(2):111508. PubMed ID: 31356815
[TBL] [Abstract][Full Text] [Related]
37. Sonodynamic therapy and common head and neck cancers: in vitro and in vivo studies.
Hajmohammadi E; Molaei T; Mowlaei SH; Alam M; Abbasi K; Khayatan D; Rahbar M; Tebyanian H
Eur Rev Med Pharmacol Sci; 2021 Aug; 25(16):5113-5121. PubMed ID: 34486685
[TBL] [Abstract][Full Text] [Related]
38. Decellularized Colorectal Cancer Matrices as Bioactive Scaffolds for Studying Tumor-Stroma Interactions.
Marques-Magalhães Â; Cruz T; Costa ÂM; Estêvão D; Rios E; Canão PA; Velho S; Carneiro F; Oliveira MJ; Cardoso AP
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053521
[TBL] [Abstract][Full Text] [Related]
39. Primary head and neck tumour-derived fibroblasts promote lymphangiogenesis in a lymphatic organotypic co-culture model.
Lugo-Cintrón KM; Ayuso JM; Humayun M; Gong MM; Kerr SC; Ponik SM; Harari PM; Virumbrales-Muñoz M; Beebe DJ
EBioMedicine; 2021 Nov; 73():103634. PubMed ID: 34673450
[TBL] [Abstract][Full Text] [Related]
40. Pancreatic Cancer Patient-Derived Organoid Platforms: A Clinical Tool to Study Cell- and Non-Cell-Autonomous Mechanisms of Treatment Response.
Piro G; Agostini A; Larghi A; Quero G; Carbone C; Esposito A; Rizzatti G; Attili F; Alfieri S; Costamagna G; Tortora G
Front Med (Lausanne); 2021; 8():793144. PubMed ID: 35004765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
